HealthLynked Corp Income Statement
HLYK|5 years of annual SEC 10-K data (FY2020-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$3M
FY2024
Gross Profit
N/A
FY2024
Operating Income
-$5M
FY2024
Net Income
-$6M
FY2024
HealthLynked Corp reported $3M in revenue and $6M in net loss for FY2024. Revenue has declined at a 16.3% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -24.77 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.0M | $5.7M | $5.9M | $6.5M | $6.1M |
| Gross Profit | - | $1.9M | - | - | - |
| SG&A Expense | $3.0M | $3.6M | $4.6M | $4.9M | $3.1M |
| Operating Income | -$4.7M | -$4.2M | -$8.7M | -$5.3M | -$3.1M |
| Interest Expense | - | $21.3K | $0 | - | - |
| Net Income | -$6.1M | -$1.0M | -$8.8M | -$10.4M | -$5.8M |
| EPS (Basic) | $0.00 | -$0.04 | -$0.05 | -$0.04 | -$0.06 |
| EPS (Diluted) | $0.00 | -$0.04 | -$0.05 | -$0.04 | -$0.06 |
| Shares Outstanding | 276.0M | 255.9M | 237.9M | 188.0M | 109.9M |
| Gross Margin | - | 32.8% | - | - | - |
| Operating Margin | -155.5% | -72.5% | -147.8% | -82.0% | -50.1% |
| Profit Margin | -203.8% | -17.7% | -150.5% | -160.3% | -93.8% |